期刊文献+

猪源性膀胱无细胞基质在异种移植中的生物安全性 被引量:1

Biological safety of porcine acellular matrix graft in xenotransplantation
下载PDF
导出
摘要 背景:猪异种移植过程中可能发生猪内源性反转录病毒跨种间传播的潜在危险,由此所带来的异种移植生物安全性问题逐渐受到关注。目的:观察去细胞过程对猪膀胱内源性反转录病毒的影响,以评价猪源性膀胱无细胞基质生物工程材料在异种移植中的生物安全性。设计、时间及地点:基因工程与组织工程动物体内实验,于2006-07/2007-03在中国医学科学院北京协和医院中心实验室完成。材料:正常健康雄性杂种犬8只,随机分为对照组2只,修补组6只,用于膀胱修补替代实验。取材0.5h内的猪新鲜膀胱标本采集自屠宰厂。方法:采用低渗-去污剂洗涤-核酸酶消化法对新鲜猪膀胱进行脱细胞处理,制备膀胱无细胞基质移植物。对照组犬切除50%膀胱后原位直接缝合,不使用任何材料修补;修补组犬切除50%膀胱后,分别用面积约为原膀胱30%,40%,50%的膀胱无细胞基质移植物进行替代修补。分别于移植前及移植后1个月抽取犬静脉血提取RNA和DNA,以猪Beta-actin序列片段扩增产物作为内参照,针对内源性反转录病毒gag区序列,选用特异性引物,采用PCR和RT-PCR法检测上述提取的DNA和RNA是否存在内源性反转录病毒序列片段,并对扩增产物进行测序用于同源性分析。主要观察指标:苏木精-伊红染色观察猪膀胱去细胞效果及DNA含量。PCR及RT-PCR扩增及测序结果。结果:经去细胞处理后,猪膀胱内的细胞成分完全去除,三维纤维支架保持完整,DNA含量低于1%。新鲜猪膀胱PCR和RT-PCR均检测到362bp扩增条带,与Medline公布的内源性反转录病毒有94%的同源性;所制备的生物工程材料膀胱无细胞基质移植物、及其移植前后的犬外周血样本均未检测到内源性反转录病毒序列的表达。结论:低渗-去污剂洗涤-核酸酶消化法制备的膀胱无细胞基质移植物可以去除猪膀胱内源性反转录病毒,能够有效预防内源性反转录病毒在 BACKGROUND: There are potential risks for interspecies spreading of porcine endogenous retrovirus during xenotransplantation. Therefore, the safety of xenotransplantation becomes a focus. OBJECTIVE: To observe the biologic safety of porcine endogenous retrovirus in xenotransplantation with porcine bladder acellular matrix. DESIGN, TIME AND SETTING: Gene engineering and tissue engineering in vivo animal trials were performed at Central Laboratory of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences between July 2006 and March 2007. MATERIALS: Eight healthy male hybrid dogs were randomly divided into control group (n=2) and experimental group (n=6) for bladder acellular matrix grafting. Fresh porcine bladder samples within 0.5 hour were harvested from butchery. METHODS: A hypotension and detergent and nucleic acid enzymatic digestion extraction process was used to remove all cellular components from the porcine bladder to prepare bladder acellular matrix graft. The dogs in control group underwent semi-cystectomy and in situ suturation. The experimental animals underwent 30%, 40% and 50% bladder acellular matrix grafting after semi-cystectomy. Blood was drawn before and 1 month after transplantation to extract RNA and DNA. With porcine Beta-actin sequence fragment amplified product as internal control, porcine endogenous retrovirus gag sequences were detected in 6 fresh porcine bladder and 6 bladder acellular matrix grafts and 5 dog peripheral blood with postgraft bladder acellular matrix graft by polymerase chain reaction (PCR) and reverse transcription polymerase chain reaction (RT-PCR) using special specific primers. MAIN OUTCOME MEASURES: Acellular effect and DNA contents were observed using HE staining. PCR and RT-PCR amplification and sequencing results were observed. RESULTS: All cell components were removed from the bladder acellular matrix. Histological analysis showed that the major structure components were maintained. The contents of the DNA in bladd
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第40期7845-7849,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献25

  • 1Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol 2004; 12(3-4):367-377 被引量:1
  • 2Sachs DH. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994;43(1-3):185-191 被引量:1
  • 3Patience-C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997;3(3):282-286 被引量:1
  • 4Popp SK, Mann DA,Milbum PJ, et al. Transient transmission of porcine endogenous retrovirus to fetal lambs after pig islet tissue xenotransplantation. Immunol Cell Biol 2007;85(3):238-248 被引量:1
  • 5Van der Laan LJ, Lockey C, Griffeth BC, et ai. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 2000;407(6800):90-94 被引量:1
  • 6Schmidt P, Forsman A, Andersson G, et al. Pig islet xenotransplantation: activation of porcine endogenous retrovirus in the immediate post-transplantation period. Xenotransplantation 2005;12(6):450-456 被引量:1
  • 7Yu P, zhang L, Bu H, et al. Zhonghua Binglixue Zazhi 2005;34(4): 220-223 被引量:1
  • 8于萍,张立,步宏,李胜富,李幼平,程惊秋.猪内源性逆转录病毒体外感染人胚肾细胞系HEK-293的初步研究[J].中华病理学杂志,2005,34(4):220-223. 被引量:1
  • 9Deng YM, Lee JH, Moran c, et al. Mapping dispersed repetitive loci using semi-specific PCR cloning and somatic cell hybrid mapping. Nucleic Acids Res 2000;28(23):E103 被引量:1
  • 10Martin U, Kiessig V, Blusch JH, et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. The Lancet 1998;352(9129):692-694 被引量:1

二级参考文献28

  • 1张玉石,李汉忠,张锐强,王彭.组织工程猪膀胱无细胞基质的制备[J].中华医学杂志,2005,85(38):2724-2727. 被引量:10
  • 2张玉石,李汉忠,张锐强,王彭,严维刚.应用Percoll分离纯化组织工程用肌卫星细胞[J].中国医学科学院学报,2006,28(2):182-185. 被引量:10
  • 3Gustafson C J, Kratz G. Tissue engineering in urology. Curr Opin Urol, 2001, 11:275-279. 被引量:1
  • 4.医疗器械生物学评价第十二部分:样品制备与参照样品[A]..医疗器械生物学评价标准汇编[C].北京:中国标准出版社,2004.80-88. 被引量:1
  • 5.医疗器械生物学评价第五部分:体外细胞毒性试验[A]..医疗器械生物学评价标准汇编[C].北京:中国标准出版社,2004.186-197. 被引量:1
  • 6Beiko DT, Knudsen BE, Watterson JD, et al Urinary tract biomaterials. J Urol, 2004, 171 (6 Pt 1) :2438-2444. 被引量:1
  • 7Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol, 2002, 13:377-383. 被引量:1
  • 8Brown AL, Farhat W, Merguerian PA, et al. 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials, 2002, 23:2179-2190. 被引量:1
  • 9Kanematsu A, Yamamoto S, Noguchi T, et al. Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor. J Urol, 2003, 170 : 1633-1638. 被引量:1
  • 10Byung-Soo K, Carlos E, Anthony A. Biomaterials for tissue engineering. World J Urol, 2000, 18:2-9. 被引量:1

共引文献18

同被引文献27

  • 1Oberpenning F, Meng l, Yoo II, et al. De novo reconstitution of a func- tional mammalian urinary bladder by tissue engineering. Nat Biotech- nol, 1999, 17(2): 149-155. 被引量:1
  • 2Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous blad- ders for patients needing cystoplasty. Lancet, 2006, 367(9518): 1241- 1246. 被引量:1
  • 3Atala A. Tissue engineering of human bladder. Br Med Bull, 2011, 97: 81-104. 被引量:1
  • 4Brown AL, Farhat W, Merguerian PA, et al. 22 week assessment of bladder acellular matrix as a bladder augmentation material in a por- cine model. Biomaterials, 2002, 23(10): 2179-2190. 被引量:1
  • 5Zhu WD, Xu YM, Feng C, et al. Bladder reconstruction with adipose- derived stem cell-seeded bladder acellular matrix grafts improve mor- phology composition. World I Urol, 2010, 28(4): 493-498. 被引量:1
  • 6Yang B, Zhang Y, Zhou L, et al. Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors fortissue engineering. Tissue Eng Part C Methods, 2010, 16(5): 1201- 1211. 被引量:1
  • 7杨斌,孙则禹,周六化,等.多孔的保留有生物活性因子的膀胱无细胞基质及制备方法:中国,ZL200810020808.0.2012-7.25. 被引量:1
  • 8Zhou L, Yang B, Sun C, et al. Coadministration of platelet-derived growth factor-BB and vascular endothelial growth factor with bladder acellular matrix enhances smooth muscle regeneration and vascular- ization for bladder augmentation in a rabbit model. Tissue Eng Part A, 2013, 19(1-2): 264-276. 被引量:1
  • 9Duan Y, Learoyd J, Meliton AY, et al. Inhibition of Pyk2 blocks airway inflammation and hyperresponsiveness in a mouse model of asthma. Am J Respir Cell Mol Biol, 2010, 42(4): 491-497. 被引量:1
  • 10Atala A. Tissue engineering, stem cells, and cloning for the regenera- tion of urologic organs. Clin Plast Surg, 2003, 30(4): 649-667. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部